Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 25 Million

Vivoryon Therapeutics Launches Capital Increase by Way of an Accelerated Bookbuild Offering
Vivoryon Therapeutics N.V. to Participate in Upcoming Conferences